ANI Pharmaceuticals | Ativo Circulante



Current Assets Alterar Data
AbbVie USD 25.58B 2.2B 2024-12
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Hikma Pharmaceutical USD 2.28B 185M 2024-06
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Novartis USD 29.7B 1.56B 2024-12
Perrigo USD 2.53B 51.1M 2025-03
Sun Pharmaceuticals INR 461.05B 26.3B 2024-09
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03



ANI Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.